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Physical Examination–Indicated Cerclage
A Systematic Review and Meta-analysis
Robert M. Ehsanipoor, MD, Neil S. Seligman, MD, Gabriele Saccone, MD, Linda M. Szymanski, MD, PhD,
Christina Wissinger, MS, MLIS, Erika F. Werner, MD, MS, and Vincenzo Berghella, MD
OBJECTIVE: To estimate the effectiveness of physical
examination–indicated cerclage in the setting of second-
trimester cervical dilatation by systematic review and
meta-analysis of published studies.
DATA SOURCES: We searched MEDLINE, EMBASE, Sco-
pus, ClinicalTrials.gov, Web of Science, and the Cochrane
Library for studies published between 1966 and 2014 that
evaluated cervical cerclage for the treatment of cervical
insufficiency.
METHODS OF STUDY SELECTION: The search yielded
6,314 citations. We included cohort studies and random-
ized controlled trials comparing cerclage placement with
expectant management of women with cervical dilata-
tion between 14 and 27 weeks of gestation. Two
investigators independently reviewed each citation for
inclusion or exclusion and discordant decisions were
arbitrated by a third reviewer. Summary estimates were
reported as the mean difference and 95% confidence
interval (CI) for continuous variables or relative risk and
with 95% CI for dichotomous outcomes. Fixed- and
random-effects meta-analysis was used, depending on
heterogeneity.
TABULATION, INTEGRATION, AND RESULTS: Ten
studies met inclusion criteria and were included in the
final analysis. One was a randomized controlled trial, two
were prospective cohort studies, and the remaining
seven were retrospective cohort studies. Of the 757
women, 485 (64%) underwent physical examination–
indicated cerclage placement and 272 (36%) were expec-
tantly managed. Cerclage was associated with increased
neonatal survival (71% compared with 43%; relative risk
1.65, 95% CI 1.19–2.28) and prolongation of pregnancy
(mean difference 33.98 days, 95% CI 17.88–50.08).
CONCLUSION: Physical examination–indicated cerc-
lage is associated with a significant increase in neonatal
survival and prolongation of pregnancy of approximately
1 month when compared with no such cerclage. The
strength of this conclusion is limited by the potential
for bias in the included studies.
(Obstet Gynecol 2015;126:125–35)
DOI: 10.1097/AOG.0000000000000850
Cervical insufficiency, previously referred to ascervical incompetence, has classically been
defined as painless dilation of the cervix in the absence
of contractions or bleeding in the second trimester.1
Painless second-trimester cervical dilation is an
uncommon finding in the general population occur-
ring in less than 1% of pregnancies.2 Cerclage for the
prevention of pregnancy loss in women with prior
second-trimester loss or second-trimester cervical dila-
tation in the index pregnancy was first reported in the
1950s.3,4 Cerclage placement in the setting of cervical
dilatation has been variably referred to as “physical
examination–indicated cerclage,” “rescue cerclage,”
and “emergency cerclage.” To date, the benefits of
cerclage for this indication are not entirely clear.
The optimal evaluation and management of
asymptomatic patients presenting with second-
trimester cervical dilatation remain controversial.
There is only one randomized controlled trial to date
evaluating the use of cerclage in this clinical scenario,
and it included only 23 patients, seven of whom were
pregnant with twins.5 Several nonrandomized studies
have compared outcomes of women receiving cerc-
lage with those expectantly managed in the setting
From the Departments of Gynecology and Obstetrics, Johns Hopkins
University, Baltimore, Maryland, University of Rochester, Rochester, New
York, and Warren Alpert Medical School of Brown University, Providence,
Rhode Island; the Department of Neuroscience, Reproductive Sciences and
Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy;
and the Division of Maternal-Fetal Medicine, Department of Obstetrics and
Gynecology, Sidney Kimmel Medical College of Thomas Jefferson University,
Philadelphia, Pennsylvania.
Corresponding author: Robert M. Ehsanipoor, MD, Johns Hopkins University
School of Medicine, 600 N. Wolfe Street, Phipps 228, Baltimore, MD 21287;
e-mail: rehsani1@jhmi.edu.
Financial Disclosure
The authors did not report any potential conflicts of interest.
© 2015 by The American College of Obstetricians and Gynecologists. Published
by Wolters Kluwer Health, Inc. All rights reserved.
ISSN: 0029-7844/15
VOL. 126, NO. 1, JULY 2015 OBSTETRICS & GYNECOLOGY 125
Copyright ª by The American College of Obstetricians
and Gynecologists. Published by Wolters Kluwer Health, Inc.
Unauthorized reproduction of this article is prohibited.
of second-trimester cervical dilatation. Observational
studies have inherent limitations, but until a well-
designed and adequately powered randomized con-
trolled study is performed, these are the best data
available on which to make management decisions.
The objective of this review was to systematically
review the literature enabling comparison and combi-
nation of the results to arrive at the most appropriate
conclusion regarding the effectiveness of physical
examination–indicated cerclage.
SOURCES
The methodology conformed to Meta-analysis of
Observational Studies in Epidemiology (MOOSE)
criteria.6 MEDLINE, EMBASE, Scopus, Clinical-
Trials.gov, Web of Science, and the Cochrane Library
were systematically searched using the keyword
search terms: “cerclage,” “cervical cerclage,” “physical
examination-indicated cerclage,” “rescue cerclage,”
“emergency cerclage,” “cervical incompetence,” “cer-
vical insufficiency,” “uterine cervix cerclage,” “uterine
cervix incompetence,” “uterine cervix insufficiency,”
“salvage cerclage,” and “cervical salvage cerclage.”
The search was conducted by an experienced librar-
ian (C.W.). References from relevant research articles
and reviews were also reviewed. No attempt was
made to search for unpublished studies. Searches were
limited to studies in humans in all languages and to
publication dates from 1966 to November 2014.
STUDY SELECTION
For inclusion, studies needed to compare cerclage
with no cerclage in women with a physical examina-
tion that revealed cervical dilatation of 0.5 cm or
greater between 14 and 27 weeks of gestation. Studies
evaluating cerclage based on ultrasound findings but
with a closed cervix were ineligible. Both prospective
and retrospective studies, including abstracts, were
included; those without a control group of expectantly
managed women were excluded.
Titles and abstracts for all of the identified studies
were independently reviewed by two reviewers (R.M.E.,
L.S.), and the full article was reviewed in further detail
when needed to determine if the study met inclusion
criteria. Any disagreements were resolved with
discussion with a third reviewer (N.S.S.). Data were
independently extracted by the two reviewers (R.M.
E. and L.S.) using previously prepared data extrac-
tion forms and any discrepancies were resolved by
discussion with a third reviewer (N.S.S.). Further
clarification and additional data were sought from
authors when required and attempts were made to
obtain patient-level data from authors. The protocol
for this review was registered in the PROSPERO
International Prospective Register of Systematic Re-
views (CRD42014015654).
Statistical analyses were conducted with Review
Manager (RevMan) 5.3. Cerclage placement was
compared with 114 no cerclage placement, and the
primary outcomes of interest were neonatal survival
and time from diagnosis to delivery. Additional out-
comes included gestational age at delivery, preterm
delivery at less than 24 weeks of gestation, delivery
between 24 and 28 weeks of gestation, delivery at less
than 34 weeks of gestation, intraoperative membrane
rupture, cervical laceration, and birth weight.
Meta-analyses were performed with cohort stud-
ies and the randomized controlled trial combined
given that there was only one randomized trial. The
studies were weighted based on the number of
participants. The data analysis was completed inde-
pendently by authors (N.S.S., G.S., V.B.). The com-
pleted analyses were then compared, and any
difference was resolved with review of the entire data
and independent analysis. Statistical heterogeneity
between studies was assessed using the Cochrane Q
statistic and Higgins I2 statistics. In case of statistically
significant heterogeneity (P value of the Cochrane Q
statistic ,.1), the random-effects model of DerSimo-
nian and Laird was used to obtain the pooled relative
risk (RR) estimate; otherwise, a fixed-effect models
was planned. The summary measures were reported
as RRs with 95% confidence intervals (95% CIs).
To further address heterogeneity, it was prede-
termined that an analysis of the studies deemed to be
at the lowest risk of bias would be performed. The
quality of each study was evaluated by two inves-
tigators (R.M.E. and N.S.S.). The Cochrane tool for
assessment of bias was used for the randomized
controlled trial and for the cohort studies, assessment
for bias was performed using an approach similar to
that described by the Cochrane Non-Randomized
Study Group.7 With this approach, differences in
baseline characteristics are compared to evaluate for
selection bias because the factors determining which
group a woman is allocated to are often unknown.
The study design and similarity of the treatment and
control groups were evaluated to estimate the risk of
bias for the following six characteristics: obstetric his-
tory, gestational age at diagnosis, cervical dilation at
diagnosis, subclinical evidence of infection, antibiotic
use, and tocolysis use. If a study reported a statistically
significant difference in parity, history of preterm
delivery, or second-trimester loss, the potential for
bias regarding obstetric history was considered to be
high. A difference of greater than 1 week for
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Table 1. Characteristics of the Included Studies
Study
Study Design,
Location, Time Participants
Primary
Outcome Inclusion Criteria Exclusion Criteria
Olatunbosun
et al,
199516
Prospective cohort
study, three
academic centers
in Nigeria, Saudi
Arabia, and
Canada, 1987–
1993
22 cerclage,
15 no
cerclage
Not stated Singleton pregnancy (20–
27 wk of gestation),
cervical dilatation 4 cm
or greater, and 50%
effaced with visible
membranes
Labor, “significant”
bleeding, evidence of
infection, history of
recurrent pregnancy loss,
potential cause for 2nd-
trimester abortion
Morin et al,
199717
Retrospective cohort
study, academic
center in Canada,
1978–1995
53 cerclage,
22 no
cerclage
Not stated Gestational age 16–26 wk
with painless cervical
dilatation
Evidence of preterm labor
Novy et al,
200118
(group 2
only)
Retrospective cohort
study, academic
center in the
United States,
1995–1999
19 cerclage,
16 no
cerclage
Not stated Gestational age 18–27 wk,
cervical dilatation 2–5
cm and 60% or greater
effacement with visible
membranes
Labor, bleeding, evidence
of infection, fetal
anomaly, uterine
anomaly, poor response
to tocolysis, previous
cerclage, known medical
cause for 2nd-trimester
abortion
Althuisius
et al, 20035
Randomized
controlled trial,
single academic
center in the
Netherlands 1995–
2000
13 cerclage
(3 twins),
10 no
cerclage
(4 twins)
Delivery at less
than 34 wk of
gestation,
compound
neonatal
morbidity,
neonatal survival
Gestational age less than 27
wk with membranes at or
beyond the cervical os
Labor, membrane rupture,
and evidence of infection
Daskalakis
et al,
200619
Prospective cohort
study, single
academic center in
Greece, 1999–
2005
29 cerclage,
17 no
cerclage
Time from
presentation to
delivery
Singleton pregnancy (18–
26 wk of gestation),
cervical dilatation
greater than 2 cm, and
membranes at or beyond
the external os
Labor, “significant”
bleeding, evidence of
infection, history of
recurrent pregnancy loss,
prior preterm birth, prior
2nd-trimester loss or
prior termination,
potential cause for 2nd-
trimester abortion uterine
anomalies, and fetal
anomalies
Pereira et al,
200820
Retrospective cohort
study, 10
international
centers, 1998–
2005
152
cerclage,
73 no
cerclage
Time from
presentation to
delivery
Singleton pregnancy (14–
25 6/7 wk of gestation),
cervical dilatation 1 cm
or greater
Ruptured membranes,
labor, bleeding,
infection, or multiple
gestation
Stupin et al,
200812
Retrospective cohort
study, academic
center in Germany,
1989–2005
89 cerclage,
72 no
cerclage
Time from
presentation to
delivery,
neonatal
survival, and
birthweight
Gestational age 17–26 wk,
cervical dilatation with
membrane prolapse
Previous operation of the
cervix in the current
pregnancy, membrane
rupture, or evidence of
infection
Ventolini
et al,
200921
Retrospective cohort
study, academic
center in the
United States,
2003–2005
56 cerclage,
12 no
cerclage
Not reported Gestational age 18–23 6/7
wk, cervical dilatation 3–
5 cm, and membranes at
or beyond below the
cervical os
Ruptured membranes,
uterine contractions,
bleeding, infection, fetal
anomaly, or multiple
gestation
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gestational age or 1 cm for dilatation at the time of
diagnosis, between the cerclage and control groups,
was considered to suggest a high risk of bias. If studies
reported on markers of inflammation or a history of
preterm delivery, a statistically significant difference
was considered to suggest a high risk of bias. When
tocolysis and antibiotic regimens were stated to be the
same for both groups, the potential for treatment bias
was considered low; if it was stated to be different, or
a statistically significant difference was shown, the
potential for treatment bias was considered to be high.
If details were not reported, it was unable to be
determined.
RESULTS
The initial search yielded a total of 6,314 titles and
abstracts. Of these, 17 met the inclusion criteria, and
seven were subsequently excluded for the one of the
following reasons: could not feasibly be translated
into English,8,9 did not adequately report results for
the control group,10 appeared to be a duplicate pub-
lication,11,12 only included patients undergoing repeat
cerclage,13 only included twins,14 or was limited to
multiple gestations attempting a delayed interval
delivery.15 Attempts were made to contact all authors
to obtain unpublished data. The remaining 10 studies
were included in the analysis, resulting in a total of
757 women eligible for a physical examination–indi-
cated cerclage.5,12,16–23 Of these, 485 (64%) women
underwent cerclage placement and 272 (36%) were
expectantly managed. Only one of the studies was
a randomized controlled trial (23 pregnancies),5 two
were prospective cohort studies,16,19 and the remain-
ing seven were retrospective cohort studies.12,17,18,20–23
Characteristics of each study are described in Table 1
and a description of the surgical procedure and asso-
ciated is provided in Table 2.
For the randomized controlled trial, randomiza-
tion was organized in balanced blocks and assigned by
telephone.5 The study was at low risk for selection
bias or bias with regard to attrition or reporting. Par-
ticipants and health care providers were not blinded,
and all of the women in the cerclage group routinely
received perioperative indomethacin; those in the bed
rest group did not. All of the women in both groups
received 1 g amoxicillin–clavulanic acid intrave-
nously every 6 hours and 500 mg metronidazole intra-
venously every 8 hours for 1 week. Blinding was not
feasible in this study, and the use of indomethacin in
the cerclage group does result in a potential for treat-
ment bias. The risk of bias for the cohort studies is
shown in Table 3. Three of the nine (33.3%) cohort
studies did not demonstrate a high risk of bias in any
of the predefined categories,16,19,21 but for one of these
studies,21 there was insufficient information to evalu-
ate six of the seven elements in the bias table. Pereira
et al20 were the only authors who performed a multi-
variate analysis to adjust for potential confounders.
The cerclage and expectantly managed groups
were similar in regard to maternal age, nulliparity,
and history of previous preterm birth. Pereira et al
reported significantly higher rates of previous second-
trimester loss in the cerclage group compared with the
expectantly managed group (45% compared with
18%, P#.01). When reported, no differences between
the groups regarding parity5,12,16,18,19,22,23 or history of
preterm birth5,16,18–20,23 were reported in any study.
Specific characteristics of the study groups are further
reported in Table 4. Women in the cerclage group
were diagnosed approximately 1 week earlier than
the expectant management group (mean difference
21.02 weeks, 95% CI 22.00 to 20.05), but there
was no significant difference in the cervical dilatation
between the cerclage group and the expectantly
Table 1. Characteristics of the Included Studies (continued )
Study
Study Design,
Location, Time Participants
Primary
Outcome Inclusion Criteria Exclusion Criteria
Curti et al,
201222
Retrospective cohort
study, two
academic centers
in Italy, 2001–
2009
37 cerclage,
15 no
cerclage
Time from
presentation to
delivery and
neonatal survival
Gestational age of 17–27
wk and cervical
dilatation 1 cm or greater
Ruptured membranes,
labor, bleeding,
infection, cervical
dilatation greater than 6
cm, or multiple gestation
Aoki et al,
201323
Retrospective cohort
study, academic
center in Japan,
2000–2012
15 cerclage,
20 no
cerclage
Not stated Gestational age of 15–26 6/
7 wk and cervical
dilatation 1–4 cm
Ruptured membranes,
treatment resistant
contractions, bleeding,
chorioamnionitis, fetal
anomalies, or multiple
gestation
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Table 2. Description of the Intervention and Associated Treatments
Study Intervention Antibiotics Tocolysis Activity
Olatunbosun
et al,
199516
Observation period: 4–6 h;
procedure: steep
Trendelenburg tilt and
inflated Foley balloon
with tip cut or retrograde
filling of the bladder used
to reduce membranes;
cerclage type: modified
McDonald; two 1 silk
pursestring sutures
followed by four 00 silk
stay sutures tied over the
external os; suture
material: silk
Ampicillin or cefoxitin35 d Ritodrine intravenous or
indomethacin
suppository348 h
Cerclage group: strict
bedrest348 h then
discharge to home in 5–6
d and advised to continue
pelvic rest; no cerclage
group: admitted for bed
rest until delivery
Morin et al,
199717
Observation period:
unspecified; procedure:
unspecified; cerclage
type: unspecified; suture
material: unspecified
Unspecified Unspecified Unspecified
Novy et al,
200118
(group 2
only)
Observation period: 4–24 h,
possible tocolysis;
procedure: steep
Trendelenburg tilt and
moist swab used to
reduce membranes;
cerclage type: modified
Shirodkar or McDonald;
suture material:
Shirodkar: Mersilene tape
(5 mm); McDonald:
“large nonabsorbable
monofilament suture”
Broad-spectrum antibiotics
frequently used but
regimens unspecified
Various agents frequently
used but unspecified
Bed rest in the hospital and
then discharged to home
and advised to continue
bed rest as feasible
Althuisius
et al, 20035
Observation period: none
stated; procedure: steep
Trendelenburg tilt and
inflated Foley balloon
used to reduce
membranes; cerclage
type: McDonald; suture
material: braided
polyester thread (metric
8/United States
Pharmacopeia 6)
All received 1 g
amoxicillin–clavulanic
acid intravenously every
6 h and 500 mg
metronidazole
intravenously every 8 h
for 1 wk
Cerclage group only
received 100 mg
indomethacin
suppository 2 h before
the procedure and 6 h
after the procedure
Inpatient bed rest until 30
wk of gestation
Daskalakis
et al,
200619
Observation period: 8–24 h;
procedure: steep
Trendelenburg tilt and
moist swab used to
reduce membranes;
cerclage type: McDonald;
suture material: polyester
cerclage tape (5 mm)
Cefuroxime and
metronidazole
intravenous348 h; 1.5 g
erythromycin orally
daily310 d
100 mg indomethacin
suppository twice
a d32 d; 5 mg ritodrine
orally every 6 h32 wk
Bed rest in the hospital37
d then discharge to home
and advised to continue
“strict bedrest” to 32 wk
and then mobilization
with “plenty of rest” until
delivery
Pereira et al,
200820
Observation period:
unspecified; procedure:
variable and unspecified;
cerclage type: variable
and unspecified; suture
material: not specified
Regimens not specified Regimens not specified Not standardized or
specified
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managed group (mean difference 20.18 cm, 95% CI
20.34 to 0.17) (Table 4). Markers of inflammation or
infection were evaluated in three of the studies12,22,23
and in one study, a higher leukocyte count was noted
in the expectantly managed group compared with the
cerclage group (median white blood cell count 9.76
K/microliter compared with 14.73 K/microliter;
mean difference 4.97, 95% CI 2.25–7.69).22 Mem-
branes were visible or prolapsed in all women in all
of the included studies with the exception of Pereira
et al20 in which membranes were not visible in 85 of
152 (56%) of the cerclage cases; this was not reported
for the expectantly managed group. Three studies
compared the degree of membrane prolapse, and
there was no significant difference between the co-
horts in any study.12,22,23 Twins were excluded in six
studies,16,19–23 included in two studies,5,18 and inclu-
sion could not be determined in two studies.12,17
The use of amniocentesis, antibiotics, and tocolysis
at the time of initial evaluation and management was
similar between the two groups (Table 4). Administra-
tion of tocolysis was reported in seven stud-
ies5,12,16,18,19,22,23 and was nearly universal with two
exceptions. In the study by Curti et al,22 34 of 52
(65%) of the women received tocolysis, and in the trial
by Althuisius et al,5 indomethacin was not used in the
expectant management group. Only two studies re-
ported on the use of amnioce2ntesis and there was
no difference between the groups (12% compared with
8%; RR 1.53, 95% CI 0.68–3.43).20,22 A sensitivity anal-
ysis was performed to evaluate for potential selection
bias that could be introduced the use of amniocentesis.
Table 2. Description of the Intervention and Associated Treatments (continued )
Study Intervention Antibiotics Tocolysis Activity
Stupin et al,
200812
Observation period:
preferably less than 24 h;
procedure: variable and
details not specified;
cerclage type: 73
McDonald, 14
combination of other
methods with fibrin
adhesive in cervical
canal, 2 Saling (see
reference); suture
material: unspecified
Regimens not specified Regimens not specified Absolute bed rest initially
and then relaxed and
lifted if asymptomatic
Ventolini
et al,
200921
Observation period: 24 h;
procedure: moist iodine-
soaked swab, retrograde
filling of the bladder used
to reduce membranes, or
both; cerclage type:
Shirodkar; Suture
material: Mersilene tape
(5 mm)
None Cerclage group only
received
indomethacin324 h
Discharged to home with
pelvic and bed rest
Curti et al,
201222
Observation period: at least
24 h; procedure: details
not specified; cerclage
type: Shirodkar n536,
McDonald n51; suture
material: Mersilene tape
(5 mm)
Ampicillin or erythromycin
intravenous37 d
Variable and regimen not
specified
Not specified
Aoki et al,
201323
Observation period: few
hours but less than 24 h;
procedure:
Trendelenburg but not
further described;
cerclage type: McDonald
n512, Shirodkar n52,
both n51; suture
material: Mersilene tape
(5 mm)
“Broad spectrum”35 d All participants received
but regimen not
specified
Cerclage group 6/15 (40%)
were temporarily
managed as outpatients;
bed rest group were all
managed inpatient;
details regarding activity
were not further
described
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After excluding the two studies in which amniocentesis
was used,20,22 the primary outcome of neonatal survival
was still significantly higher in the cerclage group com-
pared with the expectantly managed group (69.7%
compared with 50.3%; RR 1.48, 95% CI 1.06–2.05).
Shirodkar cerclage was the primary technique used in
two studies21,22; the remainder primarily used either
a McDonald cerclage5,12,19,23 or modified McDonald
cerclage,16 and, for three studies, the technique could
not be determined.17,18,20 Management strategies for
the study groups are further reported in Table 4 and
specific management and interventions for each study
are described in Table 2.
The primary outcome of neonatal survival was
reported in eight studies.5,12,16–20,22 Survival was more
likely in the cerclage group compared with the expec-
tantly managed group (71% compared with 43%; RR
1.65, 95% CI 1.19–2.28) (Table 5; Fig. 1). Cerclage
placement was associated with significant prolonga-
tion of pregnancy (mean difference 33.98 days, 95%
CI 17.88–50.08) (Fig. 2) and greater gestational age of
delivery (mean difference 4.62 weeks, 95% CI 3.89–
5.36) (Table 5). Physical examination–indicated cerc-
lage was associated with significant reductions in pre-
term birth between 24 and 28 weeks of gestation (8%
compared with 37%; RR 0.23, 95% CI 0.13–0.41),
preterm birth at less than 34 weeks of gestation
(50% compared with 82%; RR 0.55, 95% CI 0.38–
0.80), and higher birth weight (mean difference
1,028 g, 95% CI 714–1,341) (Table 5).
Table 3. Bias Assessment for Nonrandomized Studies
Study
Obstetric
History
Gestational
Age Dilatation
Evidence of
Infection Tocolysis Antibiotics
Olatunbosun et al,
199516
Low Low Low Unable to
determine
Low Low
Morin et al, 199717 Unable to
determine
Unable to
determine
High Unable to
determine
Unable to
determine
Unable to
determine
Novy et al, 200118
(group 2 only)
Low High Low Unable to
determine
Unable to
determine
Unable to
determine
Daskalakis et al, 200619 Low Low Low Unable to
determine
Low Low
Pereira et al, 200820 High High Low Unable to
determine
Unable to
determine
Unable to
determine
Stupin et al, 200812 Low High High Low Unable to
determine
Unable to
determine
Ventolini et al, 200921 Unable to
determine
Unable to
determine
Unable to
determine
Unable to
determine
Unable to
determine
Unable to
determine
Curti et al, 201222 Low High High High Low Unable to
determine
Aoki et al, 201323 Low High Unable to
determine
Low Unable to
determine
Unable to
determine
Table 4. Characteristics of the Women Included in the Meta-analysis
Characteristic Studies/Participants Cerclage Expectant Effect Estimate*
Age (y) 6/556 29.8 29.9 0.82 (20.35 to 1.95)
Nulliparous 5/331 123/192 (64) 87/139 (63) 1.02 (0.87–1.21)
Previous preterm birth 3/306 62/196 (32) 30/110 (27) 1.16 (0.80–1.68)
Gestational age at diagnosis (wk) 8/614 21.7 22.8 21.02 (22.00 to 20.05)
Cervical dilatation at diagnosis (cm) 6/556 3.3 3.5 20.18 (20.34 to 0.17)
Amniocentesis† 2/277 12/189 (12) 7/88 (8) 1.53 (0.68–3.43)
Antibiotics† 9/682 271/432 (63) 182/250 (73) 0.86 (0.78–1.15)
Tocolysis† 7/389 208/224 (93) 141/165 (85) 1.02 (0.93–1.13)
Data are weighted mean or n/N (%) unless otherwise specified.
Bold indicates statistical significance.
* Data are mean difference (95% confidence interval) for rows 1, 4, and 5 and relative risk (95% confidence interval) for rows 2, 3, 6, 7,
and 8
† At the time of initial diagnosis and management.
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In women undergoing cerclage, the incidence of
intraoperative membrane rupture was 4.1% (10 of
246)5,12,19,21–23 and for cervical laceration was 7.9%
(seven of 140)12,16,17,19; however, these data were not
reported for the control groups. The patients in which
intraoperative membrane rupture occurred were
included in the treatment group based on the princi-
ple of intention to treat for these 10 patients. Olatun-
bosun also reported one case of intraoperative
membrane rupture, but this participant was excluded
from the study.16 No maternal deaths were reported;
however, one study reported an intensive care unit
admission for sepsis in a cerclage recipient,20 but this
outcome was only specified in one other study.23
Rates of placental abruption, premature preterm rup-
ture of membranes, and chorioamnionitis were incon-
sistently and variably reported.
Six of the 10 studies were excluded from the
subanalysis of studies with the lowest risk of bias
because a high risk of bias was noted in at least one
category evaluated (Table 3).12,17,18,20,22,23 Although
the potential for treatment bias in the trial by Althui-
sius et al was high, the decision was made to include
it in the subanalysis because indomethacin in this
clinical setting has not been shown to have a signifi-
cant effect on outcomes.24 Of the remaining studies,
outcome reporting by Ventolini et al21 was insuffi-
cient to permit evaluation of bias for six of the seven
categories evaluated so it was excluded. Therefore,
the studies by Daskalakis et al, Olatunbosun et al,
and Althuisius et al were included in the subanaly-
sis.5,16,19 In the subanalysis, cerclage was also associ-
ated with higher rates of neonatal survival (78%
compared with 33%, RR 2.11, 95% CI 1.41–3.55)
and prolongation of pregnancy (mean difference
34.00 days, 95% CI 3.11–64.89).
DISCUSSION
Included articles in this meta-analysis were limited in
number and variable in quality and study design.
Although differences in our primary outcomes were
found, this meta-analysis also underscores the paucity
and low quality of existing studies of physical exam-
ination–indicated cerclage. Our findings suggest that
physical examination–indicated cerclage is associated
with significantly but modestly higher rates of neonatal
Table 5. Primary and Secondary Outcomes
Studied Outcome Studies/Participants Cerclage Expectant Effect Estimate*
Neonatal survival 8/657 294/413 (71) 106/244 (43) 1.66 (1.19–2.30)
Delivery at less than 24 wk of gestation 3/316 51/221 (23) 31/95 (33) 0.47 (0.14–1.53)
Delivery at 24—28 wk of gestation† 2/239 14/165 (8) 31/83 (37) 0.23 (0.13–0.41)
Delivery at less than 34 wk of gestation 3/316 110/221 (50) 77/94 (82) 0.55 (0.38–0.80)
Time to delivery (d) 6/385 56.7 18.8 33.98 (17.88–50.08)
Gestational age at delivery (wk) 8/643 30.6 25.2 4.62 (3.89–5.36)
Birth weight (g) 5/331 1,714.6 829.4 1,028 (714–1,341)
Data are n/N (%) or weighted mean unless otherwise specified.
Bold indicates statistical significance.
* Data are relative risk (95% confidence interval) for the top four rows and mean difference (95% confidence interval) for the bottom three
rows.
† Referent group is women who delivered either before 24 weeks of gestation or after 28 weeks of gestation.
Fig. 1. Forest plot for neonatal survival. M-H, Mantel-Haenszel test; CI, confidence interval.
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survival and significant prolongation of pregnancy
when compared with no operative intervention. Cerc-
lage was associated with statistically significant favor-
able outcomes for all secondary outcomes evaluated,
except delivery before 24 weeks of gestation.
We could not identify any meta-analysis on
the safety and effectiveness of physical examination–
indicated cerclage compared with no cerclage. Our
results are in agreement with the included studies that
had consistent findings. All studies that evaluated time
to delivery demonstrated significant prolongation
with cerclage.5,12,18–23 Additionally, the eight studies
that evaluated neonatal survival demonstrated higher
survival rates with cerclage5,12,16–20,22; however, only
three were sufficiently powered to demonstrate statis-
tical significance.12,19,20 Namouz et al25 recently con-
ducted a review of 34 studies, including case series,
evaluating physical examination–indicated cerclage.
Neonatal survival rates were similar between our
study (72.2%) and those of Namouz et al (81%). Addi-
tionally, the mean prolongation of pregnancy and ges-
tational of delivery in our study (53.8 days and 30.5
weeks, respectively) were similar to theirs (56 days
and 30.6 weeks of gestation, respectively). We could
not identify any case series describing the natural
course of expectantly managed pregnancies with
second-trimester cervical dilatation. However, our re-
sults are similar to those of Vaisbuch et al26 who re-
ported on women without cervical dilatation but no
functional cervical length. The mean prolongation of
pregnancy in our study of expectant management
(14.1 days) is comparable with the median of 21 days
reported by Vaisbuch et al. The slightly shorter inter-
val in our study seems plausible because cervical dila-
tation was already present. In those who underwent
cerclage, the 7.9% rate of cervical laceration and 4.1%
rate of intraoperative membrane rupture are consis-
tent with previously reported rates.27,28
A concern with physical examination–indicated
cerclage is that it may prolong pregnancy long enough
only to result in an extremely preterm delivery. How-
ever, we found that expectant management was asso-
ciated with a more than fourfold increased risk of
delivery between 24 and 28 weeks of gestation.
Because the majority of patients in this study were
from nonrandomized trials, the potential for bias is
strong here because clinicians may have opted for
expectant management in patients they deemed to
be at higher risk for short-term delivery. Similarly,
Aoki et al23 found that the rate of delivery between
22 and 28 weeks of gestation was 20% in the cerclage
group and 80% in the expectantly managed group
(P,.01). Pereira et al.’s20 data suggest a potential
bimodal distribution of the gestational age of delivery
in the cerclage group. This bimodal distribution sug-
gests that there may be a subset of women with a more
favorable outcome after cerclage placement and
another subset that is likely to deliver early. This
may be related to the presence of subclinical infection
and may explain why women who have undergone
amniocentesis have been shown to have more favor-
able outcomes.
The strength of this study is that it synthesizes the
results of smaller existing studies. Although pooling
data from randomized trials is preferred, appraisal and
Fig. 2. Forest plot for prolongation of pregnancy. SD, standard deviation; IV, independent variable; CI, confidence interval.
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Fig. 3. Funnel plot for assessing publication bias.
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systematic evaluation of existing observational studies
can nonetheless yield important conclusions. Although
the quality of the study methods and reporting of these
studies varied widely, the results of the subanalysis of
the highest quality studies were consistent with the
primary findings. Risk of publication bias was assessed
by visual inspection of the funnel plot and the
symmetric plot suggested no publication bias (Fig. 3).
Study quality was the most obvious limitation.
Suboptimal study design can introduce bias in a meta-
analysis of observational studies. The potential for
selection bias exists with nonrandom allocation. Nei-
ther the cerclage nor the expectant group was at an
obviously higher risk for poor outcome. Cervical
dilatation, prolapsed membranes, obstetric history,
evidence of infection, and evaluation with amniocente-
sis are factors that have been correlated with outcomes
of physical examination–indicated cerclage.29–31 In one
study, participants in the cerclage group were more
likely to have a history of second-trimester loss20 and
in another, the expectant group had a higher mean
leukocyte count.22 Otherwise, no differences were
noted in cervical dilatation, membrane prolapse, or
use of amniocentesis. The only significant difference
seen was that the mean gestational age for the cerclage
group was 22.8 weeks of gestation compared with 21.7
weeks of gestation. Cerclage placement at earlier gesta-
tional ages has been associated with improved out-
comes in some, but not all studies.30,31 The possibility
of treatment bias exists, and the use of obstetric or neo-
natal interventions such as fetal monitoring, cesarean
delivery, and neonatal resuscitation was not reported.
Neonatal outcomes were inconsistently reported and
long-term child outcomes were not reported. Despite
these limitations, the consistency of the findings of the
included studies, subanalysis, and published case series
suggests reliability.25
In summary, the current literature suggests that
physical examination–indicated cerclage is associ-
ated with markedly improved outcomes. The quality
of these studies is limited, and a randomized con-
trolled trial is warranted as are prospective studies
to identify the best candidates for cerclage. Until fur-
ther evidence is available, physical examination–
indicated cerclage should be considered in appropri-
ately selected patients.
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